PALB2 and breast cancer: Bilateral mastectomy gives more than 90% risk reduction of developing BC if a pathogenic variant is detected in BRCA1/2 and at the present time there is also enough evidence to support further consideration for risk reducing mastectomy when pathogenic variants are detected in CDH1, PALB2, and TP53 gene [11].